Search research articles
Contact Us
Filters
Showing results (11-20 of 102) with videos related to
Page
of 11
Sort By:
Diabetes Technology & Therapeutics
|
June 3, 2010
Insulin pen use for type 2 diabetes--a clinical perspective
Timothy S Bailey, Steven V Edelman
JAMA
|
November 15, 2017
Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes-Reply
Wendy Lane, Timothy S Bailey, Gregg Gerety
Journal of Diabetes Science and Technology
|
November 6, 2014
Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm
Timothy S Bailey, Anna Chang, Mark Christiansen
Diabetes Technology & Therapeutics
|
June 20, 2018
Emerging Technologies for Diabetes Care
Timothy S Bailey, John Walsh, Jenine Y Stone
Therapeutic Delivery
|
December 14, 2017
Review of a commercially available hybrid closed-loop insulin-delivery system in the treatment of Type 1 diabetes
Jenine Y Stone, Nalani Haviland, Timothy S Bailey
Diabetes Technology & Therapeutics
|
June 15, 2007
Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study
Timothy S Bailey, Howard C Zisser, Satish K Garg
Journal of Diabetes Science and Technology
|
April 4, 2022
Insulin Titration Guidelines for Patients With Type 1 Diabetes: It Is About Time!
John Walsh, Ruth Roberts, Timothy S Bailey, et al.
Diabetes/Metabolism Research and Reviews
|
April 22, 2020
Insulin glargine 300 U/mL and insulin degludec: A review of the current evidence comparing these two second-generation basal insulin analogues
Alice Cheng, Timothy S Bailey, Didac Mauricio, et al.
Current Diabetes Reports
|
October 9, 2016
Update on Clinical Utility of Continuous Glucose Monitoring in Type 1 Diabetes
Nalani Haviland, John Walsh, Ruth Roberts, et al.
Journal of Diabetes Science and Technology
|
July 26, 2017
Bolus Advisors: Sources of Error, Targets for Improvement
John Walsh, Ruth Roberts, Timothy S Bailey, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 102) with videos related to
Sort By:
Page
of 11
Diabetes Technology & Therapeutics
|
June 3, 2010
Insulin pen use for type 2 diabetes--a clinical perspective
Timothy S Bailey, Steven V Edelman
JAMA
|
November 15, 2017
Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes-Reply
Wendy Lane, Timothy S Bailey, Gregg Gerety
Journal of Diabetes Science and Technology
|
November 6, 2014
Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm
Timothy S Bailey, Anna Chang, Mark Christiansen
Diabetes Technology & Therapeutics
|
June 20, 2018
Emerging Technologies for Diabetes Care
Timothy S Bailey, John Walsh, Jenine Y Stone
Therapeutic Delivery
|
December 14, 2017
Review of a commercially available hybrid closed-loop insulin-delivery system in the treatment of Type 1 diabetes
Jenine Y Stone, Nalani Haviland, Timothy S Bailey
Diabetes Technology & Therapeutics
|
June 15, 2007
Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study
Timothy S Bailey, Howard C Zisser, Satish K Garg
Journal of Diabetes Science and Technology
|
April 4, 2022
Insulin Titration Guidelines for Patients With Type 1 Diabetes: It Is About Time!
John Walsh, Ruth Roberts, Timothy S Bailey, et al.
Diabetes/Metabolism Research and Reviews
|
April 22, 2020
Insulin glargine 300 U/mL and insulin degludec: A review of the current evidence comparing these two second-generation basal insulin analogues
Alice Cheng, Timothy S Bailey, Didac Mauricio, et al.
Current Diabetes Reports
|
October 9, 2016
Update on Clinical Utility of Continuous Glucose Monitoring in Type 1 Diabetes
Nalani Haviland, John Walsh, Ruth Roberts, et al.
Journal of Diabetes Science and Technology
|
July 26, 2017
Bolus Advisors: Sources of Error, Targets for Improvement
John Walsh, Ruth Roberts, Timothy S Bailey, et al.
Page
of 11